Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According SP Tulsian of sptulsian.com, one should not buy Tata Steel. "One may prefer Idea Cellular, which has corrected today," he adds.
Parag Doctor, Head - Trading Strategies at Keynote Capital's is of the view that one may exit Shasun Pharmaceuticals in current rally.
Jagannadham Thununguntla, Strategist & Head of Research, SMC Global Securities Limited feels Shasun Pharmaceuticals can move to Rs 92.
Lancelot D Cunha of Sharyans Wealth Management recommends to buy Dewan Housing Finance Corporation with a target price of Rs 164.10 and Shasun Pharma with a target price of Rs 55.80.
Aashish Tater of Fortunewizard.com advises buying Siti with a target price of Rs 22 and Dena Bank with a target price of Rs 74.
Sudarshan Sukhani, s2analytics.com advises to switch from Shasun Pharmaceuticals to Dr Reddy and Cipla.
SP Tulsian, sptulsian.com don‘t think that Dishman Pharma can correct below Rs 84-85. He feels the major correction seems to have got factored in. However, he still feels one should not invest in Dishman Pharma even at current levels.
In CNBC-TV18's popular show Bull's Eye, Pankaj Jain of Sunteck Wealthmax shares trading strategy of the day.